CHICAGO - (Business Wire) Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include:
Koninklijke Philips Electronics N.V. (NYSE: PHG),
Gafisa S.A. (NYSE: GFA),
Supertex, Inc. (Nasdaq: SUPX),
Motorola, Inc. (NYSE: MOT) and
General Electric Co. (NYSE: GE).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579
Here are highlights from Thursday’s Analyst Blog:
Philips N.V. Drifts Forward
Headquartered in Amsterdam, The Netherlands, Koninklijke Philips Electronics N.V. (NYSE: PHG) is one of the world's largest electronics companies and the biggest in Europe, with sales of 27 billion in 2007 and 12.4 billion in 1H08.
The company has worked to improve its cost structure, as its EBITA margins remained flat along with modest revenue performance despite the weaker-than-expected dollar. Based on these results, we are maintaining our revenue estimates for 2008.
Gafisa S.A. Affected by U.S. Crunch
Gafisa S.A. (NYSE: GFA) is extremely well positioned in the Brazilian real estate market. The company is a recognized brand and has been growing through acquisitions in order to consolidate its leading position.
The recent joint venture with Tenda will enhance the company's presence on the low-income segment. The long-term potential for growth in the local mortgage business is huge, and its massive inventory of land already acquired, as well as construction in progress, land bank and finished units is positive.
Supertex Risks Accounted For
Supertex (Nasdaq: SUPX) designs and sells high-voltage analog and mixed signal integrated circuits. The company targets the telecommunications, imaging, and medical electronic markets. In fiscal 2008, Motorola Inc. (NYSE: MOT) and General Electric Company (NYSE: GE) accounted for 13% of total sales each.
The company reported revenues of $22.8 million in Q1 of fiscal 2009, up 9.6% from a year ago and up 16.0% sequentially, mainly due to growth in shipments of medical ultra sound products which achieved record sales of $9.5 million. Operating margin also improved to 21.6% from 11.6% recorded in the previous quarter.
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=2649.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=2677
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4580.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Zacks.com
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com
